The approval gives pharmacists a new nonTNF biologic option across both major forms of pediatric inflammatory bowel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results